Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes
Authors:
Preprint
Abstract
Urine is a complex biofluid that reflects both overall physiologic state and the state of the genitourinary tissues through which it passes. It contains both secreted proteins and proteins encapsulated in tissue-derived extracellular vesicles (EVs). To understand the population variability and clinical utility of urine, we quantified the secreted and EV proteomes from 190 men, including a subset with prostate cancer. We demonstrate that a simple protocol enriches prostatic proteins in urine. Secreted and EV proteins arise from different subcellular compartments. Urinary EVs are faithful surrogates of tissue proteomes, but secreted proteins in urine or cell line EVs are not. The urinary proteome is longitudinally stable over several years. It can accurately and non-invasively distinguish malignant from benign prostatic lesions, and can risk-stratify prostate tumors. This resource quantifies the complexity of the urinary proteome, and reveals the synergistic value of secreted and EV proteomes for translational and biomarker studies.Keywords
All Related Versions
- Published version: Nature Communications, 15 (1), 1.
This publication has 63 references indexed in Scilit:
- In‐depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urineProteomics, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community AnnotationPLOS Biology, 2012
- Global quantification of mammalian gene expression controlNature, 2011
- Abacus: A computational tool for extracting and pre‐processing spectral count data for label‐free quantitative proteomic analysisProteomics, 2011
- Urine Collection and Processing for Protein Biomarker Discovery and QuantificationCancer Epidemiology, Biomarkers & Prevention, 2010
- Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of diseaseProteomics – Clinical Applications, 2009
- Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic diseaseJournal of Proteomics, 2009
- Proteomic Analysis of Conditioned Media from the PC3, LNCaP, and 22Rv1 Prostate Cancer Cell Lines: Discovery and Validation of Candidate Prostate Cancer BiomarkersJournal of Proteome Research, 2008
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996